Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Plans To Publish 'Novel' OTC Switch NPRM In May 2020

Nov 22 2019

• By Malcolm Spicer

Timetable at the Central Station

Related Content

FDA's OTC Naloxone Study Is A Starting Point For Other Switches, Not A Roadmap

May 16 2017

Final OTC Sunscreen Monograph Postponed, FDA Leadership Confirms

Nov 21 2019

Before Asking FDA For Novel OTC Switch, Be Sure DFL Alone 'Can't Get There'

May 23 2019

Cold Indication For Antihistamine Monograph Expected This Year – DNDP Director Michele

Jun 02 2016

Innovation In OTC Switches Takes Multimedia Approach In US FDA Draft Guidance

Jul 17 2018

Additional Topics

United States FDA Prescription To OTC Switch Dietary Supplements OTC Drugs Advertising, Marketing & Sales Commercial Compliance Drug Approval Standards Enforcement Ingredients Manufacturing Policy Regulation Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window